FDA seeking expanded power to combat illegal vapes: Makary
PorAinvest
lunes, 21 de julio de 2025, 2:34 pm ET1 min de lectura
FDA seeking expanded power to combat illegal vapes: Makary
The U.S. Food and Drug Administration (FDA) is pushing for expanded regulatory powers to combat the growing issue of illegal vapes, particularly those originating from China. This initiative is part of a broader effort to address the flood of illicit vapes that have been flooding the market and negatively impacting legitimate retailers.According to a letter sent by the National Association of Convenience Stores (NACS) to the Trump Administration, illicit vapes have been a significant problem for years. The letter highlights how thousands of product applications have been in regulatory limbo at the Center for Tobacco Products (CTP), leading to uncertainty and confusion for retailers. The NACS and its cosigners, including Energy Marketers of America, National Association of Tobacco Outlets, NATSO, and SIGMA, have called for swift action to address this crisis [2].
The FDA's proposed changes include requiring CTP to make decisions on all premarket applications more quickly. This would provide clarity to retailers, allowing them to determine which products can be legally sold. Additionally, the FDA is pushing for CTP to provide clear information about which products have been denied, which are in legal limbo, and which have been submitted timely applications. This transparency is crucial for small businesses that lack in-house legal teams [2].
Furthermore, the FDA is advocating for the federal multi-agency task force to be directed to take stronger enforcement actions against the worst offenders. This task force, led by the FDA and Department of Justice, should seize illicit products wherever they are found and fully utilize the FDA's authority to regulate the distribution chain [2].
The FDA is also pushing for Customs and Border Protection (CBP) to strengthen its efforts to prevent the importation of illicit Chinese vapes. This includes increasing targeted inspections, expanding the use of risk-based analytics tools, and pursuing civil and criminal penalties in cases of fraudulent import misdeclarations [2].
The proposed changes aim to create a more regulated market and limit youth access to unregulated products. However, the impact of these changes on legitimate retailers and consumers remains to be seen. While the FDA's efforts are aimed at protecting public health, they may also have unintended consequences for small businesses.
References:
[1] https://www.wect.com/2025/07/19/vapers-shop-owners-are-concerned-about-ban-products-that-arent-fda-approved/
[2] https://www.convenience.org/Media/Daily/2025/July/18/3-NACS-Asks-Trump-Admin-Chinese-Vapes_GR

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios